| References |
|
|
book American Psychiatric Association
(2001)
Diagnostic and Statistic Manual of Mental Disorders,
4th edn.
Washington: American Psychiatric Association.
|
|
|
Ashford JW and
Mortimer JA
(2002)
Non‐familial Alzheimer's disease is mainly due to genetic factors.
Journal of Alzheimers Disease
4(3):
169–177.
|
|
|
Butler AW,
Ng MY,
Hamshere ML et al.
(2009)
Meta‐analysis of linkage studies for Alzheimer's disease – a web resource.
Neurobiological Aging
30(7):
1037–1047.
|
|
|
Calero M,
Rostagno A,
Matsubara E et al.
(2000)
Apolipoprotein J (clusterin) and Alzheimer's disease.
Microscopy Research and Technique
50(4):
305–315.
|
|
|
Chabriat H,
Joutel A,
Dichgans M et al.
(2009)
CADASIL.
Lancet Neurology
8(7):
643–653.
|
|
|
Corder EH,
Saunders AM,
Risch NJ et al.
(1994)
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease.
Nature Genetics
7(2):
180–184.
|
|
|
Donnelly P
(2008)
Progress and challenges in genome‐wide association studies in humans.
Nature
456(7223):
728–731.
|
|
|
Farrer LA,
Myers RH,
Connor L et al.
(1991)
Segregation analysis reveals evidence of a major gene for Alzheimer disease.
American Journal of Human Genetics
48(6):
1026–1033.
|
|
|
Ferri CP,
Prince M,
Brayne C et al.
(2005)
Global prevalence of dementia: a Delphi consensus study.
Lancet
366(9503):
2112–2117.
|
|
|
Gatz M,
Reynolds CA,
Fratiglioni L et al.
(2006)
Role of genes and environments for explaining Alzheimer disease.
Archives of General Psychiatry
63(2):
168–174.
|
|
|
Gerrish A,
Russo G,
Richards A et al.
(2011)
The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease.
Journal of Alzheimer's Disease
28(2):
377–387. Oct 25 [Epub ahead of print].
|
|
|
Ghiso J,
Matsubara E,
Koudinov A et al.
(1993)
The cerebrospinal‐fluid soluble form of Alzheimer's amyloid beta is complexed to SP‐40,40 (apolipoprotein J), an inhibitor of the complement membrane‐attack complex.
Biochemical Journal
293(Pt 1):
27–30.
|
|
|
Goate A,
Chartier‐Harlin M‐C,
Mullan M et al.
(1991)
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.
Nature
349(6311):
704–706.
|
|
|
Harold D,
Abraham R,
Holliingwoth P et al.
(2009)
Genome‐wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.
Nature Genetics
41(10):
1088–1093. http://www.molgen.ua.ac.be/ADMutations
|
|
|
Joutel A,
Corpechot C,
Ducros A et al.
(1996)
Notch3 mutations in CADASIL, a hereditary adult‐onset condition causing stroke and dementia.
Nature
383(6602):
707–710.
|
|
|
Lambert JC,
Heath S,
Even G et al.
(2009)
Genome‐wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease.
Nature Genetics
41(10):
1094–1099.
|
|
|
Levy‐Lahad E,
Wasco W,
Poorkaj P et al.
(1995)
Candidate gene for the chromosome 1 familial Alzheimer's disease locus.
Science
269(5226):
973–977.
|
|
|
Maher B
(2008)
Personal genomes: the case of the missing heritability.
Nature
456(7218):
18–21.
|
|
|
Markus HS
(2011)
Stroke genetics.
Human Molecular Genetics
20(R2):
R124–R131.
|
|
|
May PC and
Finch CE
(1992)
Sulfated glycoprotein 2: new relationships of this multifunctional protein to neurodegeneration.
Trends in Neuroscience
15(10):
391–396.
|
|
|
Naj AC,
Jun G,
Beecham GW et al.
(2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late‐onset Alzheimer's disease.
Nature Genetics
43(5):
436–441.
|
|
|
book
Neale MC
(1995)
MX: Statistical Modeling,
3rd edn.
Richmond, VA: Department of Psychiatry.
|
|
|
Pendlebury ST and
Rothwell PM
(2009)
Prevalence, incidence, and factors associated with pre‐stroke and post‐stroke dementia: a systematic review and meta‐analysis.
Lancet Neurology
8(11):
1006–1018.
|
|
|
Pericak‐Vance MA and
Haines JL
(2009)
Beyond proof of principle: new genes for Alzheimer's disease through collaboration.
Lancet Neurology
8(11):
977–979.
|
|
|
Prakash N,
Hansson E,
Betsholtz C et al.
(2002)
Mouse Notch 3 expression in the pre‐ and postnatal brain: relationship to the stroke and dementia syndrome CADASIL.
Experimental Cell Research
278(1):
31–44.
|
|
|
Schulz UG,
Flossmann E and
Rothwell PM
(2004)
Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population‐based studies.
Stroke
35(4):
819–824.
|
|
|
Seshadri S,
Beiser A,
Pikula A et al.
(2010a)
Parental occurrence of stroke and risk of stroke in their children: the Framingham study.
Circulation
121(11):
1304–1312.
|
|
|
Seshadri S,
Fitzpatrick AL,
Ikram MA et al.
(2010b)
Genome‐wide analysis of genetic loci associated with Alzheimer disease.
JAMA
303(18):
1832–1840.
|
|
|
Sherrington R,
Rogaev EI,
Liang Y et al.
(1995)
Cloning of a gene bearing mis‐sense mutations in early onset familial Alzheimer's disease.
Nature
375(6534):
754–760.
|
|
|
Sjögren T,
Sjögren H and
Lindgren ÅG
(1952)
Morbus Alzheimer and morbus Pick; a genetic, clinical and patho‐anatomical study.
Acta Psychiatry Neurology Scandinavia (Suppliment)
82:
1–152.
|
|
|
Theuns J,
Brouwers N,
Engelborghs S et al.
(2006)
Promoter mutations that increase amyloid precursor‐protein expression are associated with Alzheimer disease.
American Journal Human Genetics
78(6):
936–946.
|
|
|
Tournier‐Lasserve E,
Joutel A,
Melki J et al.
(1991)
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12.
Nature Genetics
3(3):
256–259.
|
|
|
Urdinguio RG,
Sanchez‐Mut JV and
Esteller M
(2009)
Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies.
Lancet Neurology
8(11):
1056–1072.
|
| Further Reading |
|
|
other The knowledge of genetics in dementia is expanding at a very fast pace, and for that reason textbooks will be outdated very fast. Thus, search engines such as MedLine, Ovid and/or PubMed with relevant search words is recommended.
|